Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,055 | 164 | 89.3% |
| Honoraria | $350.00 | 1 | 10.2% |
| Education | $14.67 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $462.34 | 2 | $0 (2017) |
| PFIZER INC. | $380.17 | 15 | $0 (2023) |
| LEO Pharma Inc. | $341.43 | 20 | $0 (2023) |
| Amgen Inc. | $271.72 | 13 | $0 (2024) |
| Galderma Laboratories, L.P. | $250.40 | 22 | $0 (2018) |
| Celgene Corporation | $222.63 | 12 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $170.89 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $161.53 | 8 | $0 (2020) |
| Encore Dermatology Inc. | $144.90 | 11 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $117.94 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.88 | 4 | GENZYME CORPORATION ($75.73) |
| 2023 | $148.37 | 6 | Amgen Inc. ($54.31) |
| 2022 | $237.36 | 7 | PFIZER INC. ($138.65) |
| 2021 | $142.30 | 7 | Amgen Inc. ($77.41) |
| 2020 | $185.24 | 10 | Janssen Biotech, Inc. ($79.17) |
| 2019 | $586.94 | 32 | LEO Pharma Inc. ($109.68) |
| 2018 | $701.84 | 43 | Celgene Corporation ($133.16) |
| 2017 | $1,317 | 57 | Biofrontera Inc. ($462.34) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Immunology | ||||||
| 03/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 02/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Immunology | ||||||
| 09/25/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Inflammation | ||||||
| 08/09/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Inflammation | ||||||
| 03/21/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: DERMATOLOGY | ||||||
| 02/20/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: DERMATOLOGY | ||||||
| 01/23/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/18/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Inflammation | ||||||
| 06/20/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: DERMATOLOGY | ||||||
| 06/15/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $93.82 | General |
| Category: Inflammation & Immunology | ||||||
| 04/18/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Dermatology | ||||||
| 04/05/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/14/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Inflammation | ||||||
| 06/23/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Absorica LD (Drug), Ultravate | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Dermatology | ||||||
| 06/18/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Inflammation | ||||||
| 06/10/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation | ||||||
| 05/20/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Inflammation | ||||||
| 02/22/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Dermatology | ||||||
| 09/16/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,623 | 9,265 | $4.4M | $1.1M |
| 2022 | 23 | 2,411 | 7,567 | $4.1M | $1.0M |
| 2021 | 23 | 1,904 | 5,902 | $2.9M | $727,730 |
| 2020 | 21 | 1,880 | 5,699 | $2.0M | $537,157 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 281 | 350 | $729,398 | $221,660 | 30.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 215 | 863 | $628,046 | $138,063 | 22.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 174 | 192 | $395,640 | $116,788 | 29.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 150 | 283 | $355,259 | $110,990 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 221 | 924 | $448,370 | $93,617 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 727 | $372,634 | $79,512 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 334 | 952 | $316,247 | $78,378 | 24.8% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 76 | 160 | $192,402 | $60,395 | 31.4% |
| 67850 | Destruction of growth of eyelid margin, 1.0 cm or less | Office | 2023 | 64 | 204 | $188,816 | $42,026 | 22.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 169 | 509 | $252,788 | $31,658 | 12.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 145 | 3,334 | $93,928 | $20,973 | 22.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 68 | 81 | $97,415 | $16,669 | 17.1% |
| 13122 | Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | Office | 2023 | 68 | 81 | $45,022 | $10,092 | 22.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 152 | 291 | $83,698 | $9,399 | 11.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 38 | 40 | $52,370 | $8,902 | 17.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 80 | 151 | $74,537 | $6,744 | 9.0% |
| 13133 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, each additional 5.0 cm or less | Office | 2023 | 38 | 40 | $21,757 | $6,329 | 29.1% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 16 | 18 | $16,345 | $3,598 | 22.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $16,625 | $2,707 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $12,454 | $2,537 | 20.4% |
| 13102 | Complicated repair of wound of trunk, each additional 5.0 cm or less | Office | 2023 | 14 | 14 | $7,727 | $1,602 | 20.7% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 19 | $8,083 | $1,131 | 14.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 249 | 309 | $646,645 | $198,908 | 30.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 227 | 882 | $648,823 | $145,878 | 22.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 158 | 338 | $426,560 | $135,522 | 31.8% |
About Dr. Wayne Luo, M.D
Dr. Wayne Luo, M.D is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346267192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Luo, M.D has received a total of $3,419 in payments from pharmaceutical and medical device companies, with $99.88 received in 2024. These payments were reported across 166 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,055).
As a Medicare-enrolled provider, Luo has provided services to 8,818 Medicare beneficiaries, totaling 28,433 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 07/17/2006
- Last Updated 05/15/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346267192
Products in Payments
- Ameluz (Drug) $462.34
- EUCRISA (Drug) $286.35
- Otezla (Drug) $253.50
- DUPIXENT (Biological) $224.84
- ORACEA (Drug) $176.36
- ENSTILAR (Drug) $158.94
- PICATO (Drug) $137.88
- Impoyz (Drug) $125.08
- CIBINQO (Drug) $93.82
- Erivedge (Biological) $83.61
- TREMFYA (Drug) $79.17
- DORYX (Drug) $62.99
- Tremfya (Drug) $58.29
- EPIDUO FORTE (Drug) $54.96
- ADBRY (Biological) $44.61
- ABSORICA (Drug) $41.95
- Topicort (Drug) $38.47
- JUBLIA (Drug) $38.29
- Avar (Drug) $37.81
- VALCHLOR MECHLORETHAMINE (Drug) $34.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M